Oregon Public Employees Retirement Fund Organogenesis Holdings Inc. Transaction History

Oregon Public Employees Retirement Fund

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 26, 2023	SELL	$2.48 - $3.43 $99 - $137	-40 Reduced 0.17%	23,436 $0
Q3 2022 Nov 01, 2022	BUY	$3.14 - $6.43 $9,127 - $18,692	2,907 Added 14.13%	23,476 $76,000
Q2 2022 Jul 25, 2022	SELL	$4.74 - $8.15 $15,168 - $26,080	-3,200 Reduced 13.46%	20,569 $100,000
Q1 2022 Apr 21, 2022	SELL	$6.47 - $9.57 $3,235 - $4,785	-500 Reduced 2.06%	23,769 $181,000
Q4 2021 Feb 01, 2022	BUY	$9.02 - $13.5 $40,346 - $60,385	4,473 Added 22.6%	24,269 $224,000
Q3 2021 Oct 19, 2021	SELL	$13.71 - $17.18 $1,371 - $1,718	-100 Reduced 0.5%	19,796 $282,000
Q2 2021 Jul 23, 2021	BUY	$14.92 - $23.23 $296,848 - $462,184	19,896 New	19,896 $331,000

117

63.2M

25K

23.2K

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $408M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

Get notified when there are updates to the investment portfolio of Oregon Public Employees Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on Oregon Public Employees Retirement Fund with notifications on news.